Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,710
Closed -$319K 440
2017
Q2
$319K Buy
+4,710
New +$321K 0.03% 468
2017
Q1
Sell
-5,356
Closed -$331K 954
2016
Q4
$331K Sell
5,356
-4,326
-45% -$256K 0.02% 671
2016
Q3
$524K Buy
+9,682
New +$488K 0.02% 661
2016
Q2
Sell
-24,646
Closed -$1.21M 920
2016
Q1
$1.21M Buy
+24,646
New +$1.05M 0.07% 374
2015
Q4
Sell
-61,234
Closed -$3.15M 780
2015
Q3
$3.15M Buy
61,234
+33,764
+123% +$2.24M 0.3% 100
2015
Q2
$2.18M Buy
27,470
+23,329
+563% +$1.98M 0.31% 96
2015
Q1
$340K Buy
+4,141
New +$347K 0.09% 332
2014
Q4
Sell
-9,029
Closed -$885K 495
2014
Q3
$885K Buy
9,029
+7,319
+428% +$822K 0.36% 73
2014
Q2
$219K Buy
+1,710
New +$214K 0.11% 282
2013
Q3
Sell
-3,277
Closed -$294K 351
2013
Q2
$294K Buy
+3,277
New +$270K 0.1% 211

Other funds holding ENOV

Clinton Group's ENOV Position: Q3 2017 in Review

Clinton Group sold out of Enovis (ENOV) in Q3 2017, closing a stake of 4,710 shares — an estimated $319K sold.

Clinton Group first reported a position in ENOV in Q2 2013 and held it in 10 quarters. The position peaked at $3.15M in Q3 2015. 239 funds tracked by Wall St. Rank hold ENOV as of Q3 2017.

  • Clinton Group reported no remaining Enovis position as of Q3 2017 after selling out during the quarter.
  • Clinton Group sold 4,710 Enovis shares in Q3 2017, an estimated $319K.
  • Clinton Group first reported a position in Enovis in Q2 2013 and held it in 10 quarters.
  • Clinton Group's Enovis position peaked at $3.15M in Q3 2015.
  • 239 funds tracked by Wall St. Rank held Enovis as of Q3 2017.

Based on Clinton Group's 13F filing for Q3 2017, filed 14 Nov 2017.